Published in Blood on March 01, 1993
Iron sequestration and anemia of inflammation. Semin Hematol (2009) 1.85
Zinc porphyrins: potent inhibitors of hematopoieses in animal and human bone marrow. Proc Natl Acad Sci U S A (1997) 1.02
Management of iron deficiency anemia in inflammatory bowel disease - a practical approach. Ann Gastroenterol (2013) 1.02
Zinc protoporphyrin IX binds heme crystals to inhibit the process of crystallization in Plasmodium falciparum. Mol Med (2003) 1.00
Erythroid heme biosynthesis and its disorders. Cold Spring Harb Perspect Med (2013) 0.95
High levels of zinc-protoporphyrin identify iron metabolic abnormalities in pulmonary arterial hypertension. Clin Transl Sci (2011) 0.94
Improved method for assessing iron stores in the bone marrow. J Clin Pathol (2009) 0.92
Low hepcidin levels in severely anemic malawian children with high incidence of infectious diseases and bone marrow iron deficiency. PLoS One (2013) 0.90
Zinc erythrocyte protoporphyrin as marker of malaria risk in pregnancy - a retrospective cross-sectional and longitudinal study. Malar J (2012) 0.83
Recognising anaemia and malnutrition in vascular patients with critical limb ischaemia. Ann R Coll Surg Engl (2010) 0.77
[Anemia in patients with rheumatoid arthritis]. Z Rheumatol (2012) 0.77
Aortic compression and cross clamping in a case of placenta percreta and amniotic fluid embolism: a case report. AJP Rep (2011) 0.75
Investigating iron status in microcytic anaemia: zincprotoporphyrin and soluble transferrin receptor have a role. BMJ (2006) 0.75
Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias. Clin Chem (2015) 0.75
Prohepcidin levels in refractory anaemia caused by lead poisoning. Case Rep Gastroenterol (2008) 0.75
Roots of clinical resistance to STI-571 cancer therapy. Science (2001) 9.78
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia (2002) 3.90
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group. J Natl Cancer Inst (1998) 2.96
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML). Leukemia (2012) 2.78
Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci U S A (1998) 2.58
RNA in human leukemic cells related to the RNA of a mouse leukemia virus (leukocytes-RNA-DNA hybridization-rauscher virus-polysomal RNA). Proc Natl Acad Sci U S A (1972) 2.55
Human leukaemic cells contain reverse transcriptase associated with a high molecular weight virus-related RNA. Nat New Biol (1972) 2.40
Aneuploidy correlated 100% with chemical transformation of Chinese hamster cells. Proc Natl Acad Sci U S A (1997) 2.19
Laboratory tests of iron status: correlation or common sense? Clin Chem (1996) 2.19
Negative Haemoccult test in malignant and premalignant lesions of the colon. Validation of the Haemoccult test with total colonoscopy. Endoscopy (1989) 2.10
The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis. Nephrol Dial Transplant (1995) 2.06
[Chronic recurrent subileus due to Strongyloides stercoralis infection under immunosuppressive therapy]. Dtsch Med Wochenschr (1996) 2.04
Human sarcomas contain RNA related to the RNA of a mouse leukemia virus. Science (1972) 1.98
Viral-related RNA in Hodgkins' disease and other human lymphomas. Proc Natl Acad Sci U S A (1972) 1.98
Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol (1999) 1.77
Harmonization of molecular monitoring of CML therapy in Europe. Leukemia (2009) 1.76
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders. Blood (2001) 1.67
Control of the initiation of sporulation in Bacillus subtilis by a phosphorelay. Res Microbiol (1992) 1.64
Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR. Leukemia (1999) 1.55
How aneuploidy may cause cancer and genetic instability. Anticancer Res (2000) 1.52
Human SSAV-related endogenous retroviral element: LTR-like sequence and chromosomal localization to 18q21. Genomics (1989) 1.49
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. Haematologica (1997) 1.47
Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia (2007) 1.43
Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha. Br J Haematol (1995) 1.43
Partial nephrectomy and chronic renal failure: the 'mature' rat model. Contrib Nephrol (1988) 1.41
[The quality of the treatment of diabetics in kidney failure in Germany]. Dtsch Med Wochenschr (2000) 1.38
Anaemia in dialysis patients as a side-effect of sartanes. Lancet (1998) 1.38
Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission. Leukemia (2003) 1.37
Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. Proc Natl Acad Sci U S A (2000) 1.36
Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories. Leukemia (2007) 1.33
Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis (2001) 1.31
Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha. Leukemia (2002) 1.31
Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis. Leukemia (2006) 1.27
Retrovirus-like particles released from the human breast cancer cell line T47-D display type B- and C-related endogenous retroviral sequences. J Virol (1995) 1.27
Central role of zinc protoporphyrin in staging iron deficiency. Clin Chem (1994) 1.26
Treatment of chronic myeloid leukemia in blast crisis. Haematologica (2008) 1.25
Genomic distribution and transcription of solitary HERV-K LTRs. Genomics (1993) 1.24
[Reaction of normal and pathologically changed human skin on intracutaneously and epicutaneously applied endopeptidases (trypsin, bromelin)]. Arch Klin Exp Dermatol (1965) 1.23
RNA related to that of a murine leukemia virus in Burkitt's tumors and nasopharyngeal carcinomas. Proc Natl Acad Sci U S A (1973) 1.23
Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients. Leukemia (2006) 1.22
Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability. Leukemia (2005) 1.21
Re-emergence of interferon-α in the treatment of chronic myeloid leukemia. Leukemia (2012) 1.21
Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia. Leukemia (2011) 1.21
A comparative study of the biologic and molecular basis of murine mammary carcinoma: a model for human breast cancer. J Natl Cancer Inst (1973) 1.19
Evidence for RNA tumor viruses in human lymphomas including Burkitt's disease. Cancer Res (1973) 1.19
Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin by front-face hematofluorometry. Clin Chem (1992) 1.17
Proviral structure, chromosomal location, and expression of HERV-K-T47D, a novel human endogenous retrovirus derived from T47D particles. J Virol (1998) 1.13
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. Leukemia (2003) 1.11
Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy. Proc Natl Acad Sci U S A (2001) 1.11
Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma. Leukemia (2002) 1.09
Oncogenic retrovirus from spontaneous murine osteomas. II. Molecular cloning and genomic characterization. Virology (1986) 1.09
Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization. Leukemia (2002) 1.08
Endogenous retroviral elements in human DNA. Cancer Res (1990) 1.07
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia (2009) 1.07
Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1989) 1.07
Aneuploidy precedes and segregates with chemical carcinogenesis. Cancer Genet Cytogenet (2000) 1.06
[Current therapeutic concept of acute promyelocytic leukemia]. Dtsch Med Wochenschr (2001) 1.05
Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood (1996) 1.04
The t(8;17)(p11;q23) in the 8p11 myeloproliferative syndrome fuses MYO18A to FGFR1. Leukemia (2005) 1.03
Detection and quantification of residual disease in chronic myelogenous leukemia. Leukemia (2000) 1.02
Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay. J Clin Microbiol (2006) 1.02
Gastric mucosal dysplasia: what is its clinical significance? Front Gastrointest Res (1979) 0.99
Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J Invest Dermatol (1999) 0.97
Expression of interferon regulatory factor (IRF) genes and response to interferon-alpha in chronic myeloid leukaemia. Leukemia (1997) 0.96
A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia. Blood (1996) 0.96
Identification of the nusB gene product of Escherichia coli. Mol Gen Genet (1981) 0.96
Expression of interferon regulatory factor 4 in chronic myeloid leukemia: correlation with response to interferon alfa therapy. J Clin Oncol (2000) 0.95
Mutants of bacteriophage T2 gt with altered DNA methylase activity. J Mol Biol (1972) 0.94
Isolation of an SSAV-related endogenous sequence from human DNA. Virology (1986) 0.94
Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection-case report and review of the literature. Ann Hematol (2003) 0.94
Diagnostic significance of quantitative determination of HIV antibody specific for envelope and core proteins. Lancet (1987) 0.92
Effects of septic shock on renal function in humans. Ann Surg (1967) 0.92
Retrovirus-like particles from the human T47D cell line are related to mouse mammary tumour virus and are of human endogenous origin. J Gen Virol (1992) 0.92
[Gastric mucosal dysplasias: what is their clinical significance (author's transl)]. Dtsch Med Wochenschr (1975) 0.92
RNA tumor viruses and human cancer. Curr Top Microbiol Immunol (1976) 0.92
Molecular evidence for a viral etiology of human leukemias, lymphomas, and sarcomas. Am J Clin Pathol (1973) 0.91
S71 is a phylogenetically distinct human endogenous retroviral element with structural and sequence homology to simian sarcoma virus (SSV). Virology (1990) 0.91
Interferon alpha in the treatment of polycythemia vera. Ann Hematol (2000) 0.90
Cannulation of subclavian vein for hemodialysis using Seldinger's technique. Trans Am Soc Artif Intern Organs (1978) 0.90
Analysis of p73 and p53 gene deletions in multiple myeloma. Leukemia (1999) 0.90
bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements. Br J Haematol (2001) 0.90
Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha. Leukemia (2005) 0.89
Auer rod-like inclusions in multiple myeloma. Ann Hematol (2002) 0.89
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha. Leukemia (2003) 0.89
Analysis and validation of prognostic factors for CML. German CML Study Group. Bone Marrow Transplant (1996) 0.89
Chronic myelogenous leukemia: molecular and cellular aspects. J Cancer Res Clin Oncol (1998) 0.88